In the last decade, interventions involving orthobiologics, like platelet rich plasma (PRP), have been providing relief and new hope for tissue and joint damage. Many patients with conditions like osteoarthritis, degenerative disc disease and tendinosis are finding significant, long-term improvement from orthobiologics the use of natural substances like platelets and stem cells to help musculoskeletal injuries heal.
Dr. Matthew Gnirke, a physiatrist at Vail-Summit Orthopaedics & Neurosurgery, specializes in orthobiologics. He employs PRP and bone marrow aspirate concentrate (BMAC) to get people back to the sports and activities they love.
What is it?
PRP and BMAC both use platelets from the patients own body.
PRP interventions involve a simple blood draw about 60cc, which is anticoagulated (to prevent blood clotting) and spun to separate different cell types. Physicians then collect the platelets, which are the least dense cells, and inject them into a joint or other damaged site.
BMAC interventions also use platelets, along with a small amount of stem cells; these mesenchymal stem cells have the ability to differentiate (or turn into) cells that produce cartilage, tendons, ligaments and muscles. They are sourced from bone marrow through a needle. The procedure can be done in office, or, if a patient prefers sedation, in a surgical setting.
BMAC is not a surgical procedure, but it can cause pain, he said. The response is highly variable. Many patients describe it as a deep Charlie horse in the buttock. Some feel it less, some more, but the vast majority of patients do tolerate it in the office and sedation is not necessary.
BMAC is often used for more advanced osteoarthritis and disc diseases, whereas PRP is used for early stage osteoarthritis, joint issues and tendon disorders like tendinosis (the latter of which is caused by degeneration of a tendons collagen from chronic overuse, such as tennis elbow).
Platelets act like microscopic, natural surgeons, Gnirke said. They attach to damaged collagen fibers, which are the fundamental building blocks of tendons, ligaments and muscles. One platelet contains over 1,200 growth factors within it, he said. PRP treatment typically releases at least 1 million platelets into an injured area, releasing growth factors involved in collagen repair and synthesis.
They are truly wound-healing cells, Gnirke said.
What can it help?
Orthobiologics are referred to as regenerative medicine because they actually help heal rather than simply masking symptoms like steroid shots do. They are used to treat damaged tendons, ligaments, muscles, joints and discs.
Gnirke has seen patients with early stage osteoarthritis of the knee and other joints, as well as conditions like tennis elbow, improve significantly. These conditions result from slow degradation over time, as collagen fibers lose strength and density and tend to get microtears.
The earlier you catch it, the more likely youre able to see long term trajectory changing improvement, he said.
He recommends people come in for an evaluation as soon as symptoms affect them regularly or impact function. Even if you can still ski, bike, hike and do what you love, if youre modifying movements or aware of discomfort, it often indicates mild to moderate disease, he said. Grinning and bearing pain or stiffness could lead to further breakdown of tissues and joints, which can progress to more severe osteoarthritis (like bone on bone knee damage) or severe disc degeneration and associated pain.
Gnirke finds orthobiologics quite effective for lower back pain related to degenerative disc disease, he said. Studies show an improvement in back pain in two out of three patients over the long term.
In the past, physical therapy and/or anti-inflammatories, then surgery was used to treat degenerative disc disease there werent many options in-between. Orthobiologics bridge that gap.
Originally used in sports medicine for professional athletes, PRP and BMAC are now available to the general public. Though most insurances still view them as experimental treatments, workmans compensation insurance and Kaiser Permanente are paving the way for other companies to cover the procedures. No one knows when (or if) that will happen, but its still probably years away. Until then, patients can pay out of pocket (usually under $1,000 for PRP).
Studies show that 65% to 75% of patients respond positively to PRP and BMAC.
Over 2/3 of patients see significant, long-term improvement for greater than one to two years, Gnirke said.
How the procedure works
Once platelets (and stem cells, in the case of BMAC) are collected, Gnirke delivers injections into the site of injury, using ultrasound or x-ray to ensure the exact site of injection.
Patients often temporarily feel worse before they get better: Pain flare ups range from mild to severe and can last anywhere from one day to up to two weeks. The longer, more severe reactions usually occur with spinal injections, he said. Within a month, patients usually feel theyre at baseline: not better, not worse.
Typically, it takes about six to eight weeks to start feeling improvement; it can take four to six months, and even up for a year if its a spinal injection, for improvements to fully take effect. Of course, regenerative medicine is just one of the procedures Gnirke employs. His practice focuses on proper diagnosis, prevention, treatment and rehabilitation of musculoskeletal injuries and disorders. He avoids overtreating and doesnt believe in preemptive orthobiologics where theyre not needed. His main interest: getting people back to doing what they love.
Visit link:
Regenerative Medicine provides new hope and healing - Vail Daily News
- Instructing iPS cell-derived mesenchymal stem cells to inhibit abnormal bone formation in FOP - Medical Xpress - March 28th, 2024
- Clinical application of mesenchymal stem cell in regenerative medicine ... - March 22nd, 2024
- Mesenchymal Stem Cells: The Past Present and Future - March 22nd, 2024
- CytoMed Diversifies into Regenerative Medicine after Research Collaboration with Singapore's Sengkang General ... - Yahoo Finance - March 20th, 2024
- Overexpression of Wnt5a promoted the protective effect of mesenchymal stem cells on Lipopolysaccharide-induced ... - BMC Infectious Diseases - March 20th, 2024
- Mesenchymal Stem Cells: What We Have Learned and How to Manage Them - MDPI - March 17th, 2024
- Mesenchymal stem cells and their microenvironment - March 17th, 2024
- Mesenchymal stem/stromal cells as a valuable source for the treatment ... - March 17th, 2024
- Proteomic characterization of hUC-MSC extracellular vesicles and evaluation of its therapeutic potential to treat ... - Nature.com - March 13th, 2024
- The impact understanding of exosome therapy in COVID-19 and preparations for the future approaches in dealing with ... - Nature.com - March 13th, 2024
- CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to ... - Yahoo Finance UK - March 7th, 2024
- CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to ... - Yahoo Finance - March 6th, 2024
- Combatting osteoarthritis with cartilage replacement therapy - Drug Target Review - March 3rd, 2024
- Ethical considerations in Stem Cell therapy for ALS - Cyprus Mail - February 27th, 2024
- Therapeutic Solutions International Files Patent on Facilitating Effects of JadiCells on Gene Therapy Mediated Cell ... - Business Wire - February 27th, 2024
- Stem Cell Therapy for Ulcerative Colitis - Health Central - February 27th, 2024
- Expanding the Horizons of Cell and Gene Therapy - RegMedNet - February 24th, 2024
- Early differentiation of mesenchymal stem cells is reflected in their dielectrophoretic behavior | Scientific Reports - Nature.com - February 22nd, 2024
- Orthopaedics Department's Regenerative Research Highlighted at ORS Annual Meeting - InventUM - University of Miami - February 20th, 2024
- Cellular uptake and in vivo distribution of mesenchymal-stem-cell-derived extracellular vesicles are protein corona ... - Nature.com - February 18th, 2024
- New University spin-out developing novel adult stem cell-based Therapies - News - University of Liverpool - News - February 15th, 2024
- Examining the potential of the common bovine as a potential therapeutic research model - Medical Xpress - February 15th, 2024
- Intentional Interference: Genetic Engineering Medium Aids The Transfection Of MSCs With siRNA - BioProcess Online - February 15th, 2024
- Cellular senescence is associated with osteonecrosis of the femoral head while mesenchymal stem cell conditioned ... - Nature.com - February 9th, 2024
- Stem Cell Therapy for Crohns Disease Shows Promising Results - RegMedNet - February 9th, 2024
- Targeted transcriptomic analysis of synovial tissues from horses with septic arthritis treated with immune-activated ... - American Veterinary Medical... - February 7th, 2024
- Mesenchymal Stem Cell Immunomodulation: Mechanisms and ... - Cell Press - February 7th, 2024
- New Cell Therapy for ARDS: A Groundbreaking Development and Other Respiratory Health Breakthroughs - Medriva - February 7th, 2024
- Effective treatment of optic neuropathies by intraocular delivery of MSC-sEVs through augmenting the G-CSF ... - pnas.org - January 31st, 2024
- Global Stem Cell Therapy Industry Outlook to 2028, Driven by Therapeutic Innovations and Clinical Advancements ... - Yahoo Finance - January 29th, 2024
- Out-of-this-world study will test how stem cells function in space - YP - January 29th, 2024
- The Applications of Cell Therapy - Technology Networks - January 26th, 2024
- STEM CELL THERAPY FOR MS COST: WHAT YOU NEED TO KNOW? - Island Echo - January 24th, 2024
- Understanding Neuromyelitis Optica: Role of NF-B and Therapeutic Potential - Medriva - January 20th, 2024
- Faculty member Arnold Caplan passes away The Daily The Daily - The Daily | Case Western Reserve University - January 18th, 2024
- Effects of fine particulate matter on bone marrow-conserved hematopoietic and mesenchymal stem cells: a systematic ... - Nature.com - January 11th, 2024
- Expression of HLA-DR by mesenchymal stromal cells in the platelet lysate era: an obsolete release criterion for MSCs ... - Journal of Translational... - January 11th, 2024
- NurOwn and its exosomes for ALS given patents in Europe, elsewhere - ALS News Today - January 8th, 2024
- Single-cell analysis reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of ovarian ... - Nature.com - January 8th, 2024
- First in Class Combination Stem Cell and Exosome Therapy to Treat Pulmonary Fibrosis in Long Haul Covid Patients ... - Yahoo Finance - January 4th, 2024
- Choosing the Right Excipients for MSC and iPSC Therapies - Pharmaceutical Technology Magazine - January 4th, 2024
- Mitochondria Transplantation Therapy It's Farther Along Than You Think - BioProcess Online - January 2nd, 2024
- Embryonic-stem-cell-derived mesenchymal stem cells relieve experimental contact urticaria by regulating the functions ... - Nature.com - December 21st, 2023
- Type I collagen and fibromodulin enhance the tenogenic phenotype of hASCs and their potential for tendon ... - Nature.com - December 19th, 2023
- Could the 'central dogma' of biology be misleading bioengineers? - Phys.org - December 13th, 2023
- The Risks of Stem Cell and Exosome Treatments for Long COVID: A Call for Stricter Regulations - Medriva - December 13th, 2023
- Mesenchymal stem cells from biology to therapy - PMC - December 11th, 2023
- The Safety and Efficacy of Human Umbilical Cord-Derived ... - Cureus - December 5th, 2023
- The pivotal role of Nrf2 signal axis in IDD | JIR - Dove Medical Press - December 5th, 2023
- Futuristic Novel Therapeutic Approaches in the Treatment of ... - Cureus - December 3rd, 2023
- Cartilage's Contribution in Otology: A Comprehensive Review of Its ... - Cureus - December 3rd, 2023
- Mesenchymal stem or stromal cells: a review of clinical applications ... - November 29th, 2023
- Comparative evaluation of 3D-printed and conventional implants in ... - Nature.com - November 29th, 2023
- Expression of E-cadherin and N-cadherin in Epithelial-to ... - Cureus - November 29th, 2023
- Enhancing the immunosuppressive properties of human umbilical cord mesenchymal stem cells - Phys.org - November 29th, 2023
- 'Great Potential' in Stem Cell Therapies for Knee Osteoarthritis ... - Pain News Network - November 25th, 2023
- Dietary Sources, Bioavailability, and Functions of Ascorbic Acid ... - Cureus - November 25th, 2023
- FY 2024 VA-Funded Projects - VA's Office of Research and Development - November 25th, 2023
- Real-world data suggest effectiveness of the allogeneic ... - Journal of Translational Medicine - November 23rd, 2023
- Mesenchymal Stem Cells: Characteristics, Function, and Application - November 23rd, 2023
- Combined application of therapeutic viruses and nanomaterials to ... - News-Medical.Net - November 23rd, 2023
- Progress in the Development of Stem Cell-Derived Cell-Free ... - Dove Medical Press - November 23rd, 2023
- Improving the therapeutic efficacy of oncolytic viruses for cancer ... - Journal of Translational Medicine - November 23rd, 2023
- 11.22.23 -- How To Lose A Batch In 10 Days - BioProcess Online - November 23rd, 2023
- The Pros and Cons of Mesenchymal Stem Cell-Based Therapies - November 19th, 2023
- Leptin's influence on MMP-1 expression | JIR - Dove Medical Press - November 15th, 2023
- TWIST1 and TSG6 are coordinately regulated and function as ... - Science - November 11th, 2023
- Association between severe acute malnutrition in childhood and ... - BioMed Central - November 11th, 2023
- Global Market for Treatments for Syndromes of Progressive Ataxia and Weakness Disorders - Yahoo Finance - November 11th, 2023
- Stem Cell Restore Reviews - Does It Work? Real Green Valley ... - The Daily World - November 11th, 2023
- Biological and genetic characterization of a newly established ... - Nature.com - November 11th, 2023
- Placental Stem Cell Collection and Storage Industry Scope ... - Argyle Report - November 9th, 2023
- In Vitro Evaluation of Light-Induced Cytotoxic Property: Synergistic ... - Cureus - November 9th, 2023
- UF professor launches nonprofit to equalize cell-based therapy access - Mainstreet Daily News Gainesville - November 7th, 2023
- Who are the leading innovators in cell immunomodulation for the ... - Pharmaceutical Technology - November 7th, 2023
- The Association of Vitamin D, Growth/Differentiation Factor 5 (GDF-5 ... - Cureus - November 7th, 2023
- Outcome of Physiotherapy Treatment on a 28-Year-Old Male ... - Cureus - November 7th, 2023
- Prognostic and immunotherapeutic significance of immunogenic cell ... - Nature.com - November 7th, 2023
- Cell Processing Solution Market to Witness Massive Growth by 2030 ... - Argyle Report - November 7th, 2023
- MDA-9/Syntenin in the tumor and microenvironment defines prostate ... - pnas.org - November 5th, 2023
Recent Comments